January 6, 2022 natcopharma-wpdmn No Comments NATCO completes acquisition of Dash Pharmaceuticals LLC Read more > Read More
December 6, 2021 natcopharma-wpdmn No Comments NATCO receives approval for a drug for the treatment of Covid-19 in India Read more > Read More
December 6, 2021 natcopharma-wpdmn No Comments NATCO proposes to acquire Dash Pharmaceuticals LLC Read more > Read More
November 6, 2021 natcopharma-wpdmn No Comments NATCO launches Tipanat tablets in India, for the treatment of advanced colorectal and gastric cancer Read more > Read More
October 6, 2021 natcopharma-wpdmn No Comments NATCO announces launch of its 10mg strength for Everolimus Tablets (generic for Afinitor®) in the US market Read more > Read More
August 4, 2021 natcopharma-wpdmn No Comments NATCO transfers Lenalidomide ANDA to Arrow Read more > Read More
June 14, 2021 natcopharma-wpdmn No Comments NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS® ) in the US market Read more > Read More
May 26, 2021 natcopharma-wpdmn No Comments NATCO receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA®) ANDA in the US market Read more > Read More
May 22, 2021 natcopharma-wpdmn No Comments NATCO receives USFDA approval for Lenalidomide Capsules Read more > Read More
May 21, 2021 natcopharma-wpdmn No Comments NATCO starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment Read more > Read More
May 17, 2021 natcopharma-wpdmn No Comments NATCO signs Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19 in India Read more > Read More
May 3, 2021 natcopharma-wpdmn No Comments NATCO receives Emergency Use approval for Baricitinib tablets for Covid-19 treatment Read more > Read More
April 26, 2021 natcopharma-wpdmn No Comments NATCO seeks Emergency approval of Molnupiravir capsules for Covid-19 treatment Read more > Read More
March 26, 2021 natcopharma-wpdmn No Comments NATCO receives final approval for Everolimus tablets (generic for Afinitor® ) for the US market Read more > Read More
February 26, 2021 natcopharma-wpdmn No Comments NATCO launches Brivaracetam tablets, in India, for treatment of epilepsy Read more > Read More
January 1, 2021 natcopharma-wpdmn No Comments NATCO receives final approval for Everolimus tablets (generic for ZORTRESS9) in the US market Read more > Read More
